CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $120.23M, lower than 95% of all stocks globally
- PositionCurrent ratio is 0.43×, lower than 95% of its Medical Instruments & Supplies peers (median 2.21×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
171.35BKRW120.23M · vs all stocks (USD)
Revenue (TTM)
77.07BKRW54.08M · vs all stocks (USD)
Profit Margin
-6.58%vs Medical Instruments & Supplies peers
Beta
0.6360xvs all stocks
52-Week Change
-34.96%vs all stocks
Market Capitalization
171.35BKRW120.23M · vs all stocks (USD)
Enterprise Value
272.44BKRW191.16M · vs all stocks (USD)
Price to Sales (TTM)
2.14xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.35xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.54xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
23.27xvs Medical Instruments & Supplies peers
Gross Margin
50.92%vs Medical Instruments & Supplies peers
Profit Margin
-6.58%vs Medical Instruments & Supplies peers
Operating Margin
-4.16%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.95%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-8.18%vs Medical Instruments & Supplies peers
Revenue (TTM)
77.07BKRW54.08M · vs all stocks (USD)
Revenue per Share (TTM)
2.14KKRWUpdated Jul 15, 2026Quarterly Revenue Growth
1.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
37.63BKRW26.41M · vs all stocks (USD)
EBITDA (TTM)
9.68BKRW6.79M · vs all stocks (USD)
Net Income (TTM)
-5.07BKRW-3.56M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
1.08%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
9.17BKRW6.43M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-16.87BKRW-11.83M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
-456.30MKRWFY2025 · Dec 31, 2025Revenue
76.90BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
40.06BKRWFY2025 · Dec 31, 2025Gross Profit
36.84BKRWFY2025 · Dec 31, 2025Operating Income
3.82BKRW2.68M · vs all stocks (USD)
Pre-tax Income
-7.69BKRWFY2025 · Dec 31, 2025Income Tax Expense
-252.63MKRWFY2025 · Dec 31, 2025Net Income
-7.44BKRWFY2025 · Dec 31, 2025EBIT
2.89BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
8.45BKRWFY2025 · Dec 31, 2025Research & Development
10.03BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
8.87BKRWFY2025 · Dec 31, 2025Other Operating Expenses
1.46BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
310.63MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
10.58BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-7.44BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
838.00MKRWFY2025 · Dec 31, 2025Operating Cash Flow
8.36BKRWFY2025 · Dec 31, 2025Free Cash Flow
2.71BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.89BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-7.44BKRWFY2025 · Dec 31, 2025Stock-based Compensation
-305.27MKRWFY2025 · Dec 31, 2025Other Non-cash Items
14.16BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
94.47MKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
1.86BKRWFY2025 · Dec 31, 2025Capital Expenditures
-5.65BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-10.14BKRWFY2025 · Dec 31, 2025Net Acquisitions
9.02MKRWFY2025 · Dec 31, 2025Purchase of Investments
-1.68BKRWFY2025 · Dec 31, 2025Sale of Investments
3.15BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-4.17BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
12.00BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-33.61BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
2.29BKRWFY2025 · Dec 31, 2025Common Stock Repurchase
-1.20BKRWFY2025 · Dec 31, 2025Other Financing Charges
-59.99MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-19.29BKRWFY2025 · Dec 31, 2025Shares Outstanding
37.21MSharesUpdated Jul 15, 2026Float Shares
25.91MSharesUpdated Jul 15, 2026% Held by Insiders
29.43%vs all stocks
% Held by Institutions
0.41%vs all stocks
Total Cash (MRQ)
5.69BKRW3.99M · vs all stocks (USD)
Total Cash per Share (MRQ)
155.64KRWUpdated Jul 15, 2026Total Debt (MRQ)
116.16BKRW81.51M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.60xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.4300xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
1.96KKRWUpdated Jul 15, 2026Total Assets
209.14BKRW146.74M · vs all stocks (USD)
Total Current Assets
31.30BKRWFY2025 · Dec 31, 2025Total Liabilities
144.13BKRWFY2025 · Dec 31, 2025Total Non-current Assets
177.84BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
60.38BKRWFY2025 · Dec 31, 2025Total Current Liabilities
83.76BKRWFY2025 · Dec 31, 2025Cash Equivalents
4.89BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.89BKRWFY2025 · Dec 31, 2025Other Short-term Investments
336.41MKRWFY2025 · Dec 31, 2025Accounts Receivable
5.21BKRWFY2025 · Dec 31, 2025Inventory
17.08BKRWFY2025 · Dec 31, 2025Accounts Payable
2.33BKRWFY2025 · Dec 31, 2025Short-term Debt
66.69BKRWFY2025 · Dec 31, 2025Other Current Liabilities
-260.00KRWFY2025 · Dec 31, 2025Long-term Debt
50.47BKRWFY2025 · Dec 31, 2025Common Stock (Book)
18.00BKRWFY2025 · Dec 31, 2025Retained Earnings
-24.22BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
65.00BKRW45.61M · vs all stocks (USD)
52-Week Low
4.04KKRWUpdated Jul 15, 202652-Week High
11.28KKRWUpdated Jul 15, 202652-Week Change
-34.96%vs all stocks
Beta
0.6360xvs all stocks
50-Day MA
5.37KKRWUpdated Jul 15, 2026200-Day MA
6.80KKRWUpdated Jul 15, 2026Avg 10-Day Volume
152.93KSharesUpdated Jul 15, 2026Avg 30-Day Volume
211.22KSharesUpdated Jul 15, 2026Diluted EPS (TTM)
-184.00KRWUpdated Jul 15, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.43×, lower than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 0.43Industry median: 2.21Industry P5: 0.86Peers compared: 65.00
Debt-to-equity is 1.6×, higher than 95% of its Medical Instruments & Supplies peers (median 0.23×)Significant
Debt-to-equity: 1.60Industry median: 0.23Industry P95: 1.26Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.51Profit Margin: -0.07
Financial Health
Altman Z-Score 0.66: distress zoneCritical
Altman Z-Score: 0.66
High earnings qualityNotable
Earnings Quality Score: 0.96
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $120.23M, lower than 95% of all stocks globallySignificant
Market cap (USD): 120,227,968.142Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Shinsung ST Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Smec Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
0015G0
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wynnstay Group plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
SDI Group PLC
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Auros Technology Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Tigo Energy Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Dae-Il Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sos Lab Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Alumasc Group plc
Tier 1ProductionThroughput-Bound ConversionFlowRule